Variant report
Variant | nsv981403 |
---|---|
Chromosome Location | chr7:96934701-96946503 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73392145 | chr7:96935212-96935213 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs536788689 | chr7:96935229-96935230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187595697 | chr7:96935234-96935235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567278645 | chr7:96935241-96935242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535889928 | chr7:96935256-96935257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs41342645 | chr7:96935261-96935262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs41474050 | chr7:96935274-96935275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535177002 | chr7:96935297-96935298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558437233 | chr7:96935369-96935370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs578138548 | chr7:96935451-96935452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192544078 | chr7:96935525-96935526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543968939 | chr7:96935626-96935627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542106288 | chr7:96935663-96935664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143306843 | chr7:96935672-96935673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs560743201 | chr7:96935734-96935735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573953398 | chr7:96935735-96935736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs527744561 | chr7:96935795-96935796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184842595 | chr7:96935861-96935862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559561138 | chr7:96935879-96935880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs117665874 | chr7:96935922-96935923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs189305466 | chr7:96936146-96936147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76536837 | chr7:96936163-96936164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564769852 | chr7:96936227-96936228 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs181634325 | chr7:96936258-96936259 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550231345 | chr7:96936289-96936290 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs10248224 | chr7:96936295-96936296 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs201396896 | chr7:96936299-96936300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs202083098 | chr7:96936314-96936315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73711821 | chr7:96936337-96936338 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs546281157 | chr7:96936402-96936403 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184283592 | chr7:96936440-96936441 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73711823 | chr7:96936450-96936451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs2058668 | chr7:96936491-96936492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs578232213 | chr7:96936552-96936553 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190107175 | chr7:96936568-96936569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181351971 | chr7:96936662-96936663 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs140576782 | chr7:96936698-96936699 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542964838 | chr7:96936711-96936712 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs535486155 | chr7:96936751-96936752 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs531767986 | chr7:96936770-96936771 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2394621 | chr7:96936777-96936778 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs74501244 | chr7:96936824-96936825 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs376846920 | chr7:96936825-96936826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs116398847 | chr7:96936827-96936828 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544928812 | chr7:96936853-96936854 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10233208 | chr7:96936901-96936902 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs530584406 | chr7:96936912-96936913 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs186325947 | chr7:96936914-96936915 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560992033 | chr7:96936961-96936962 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190828302 | chr7:96936966-96936967 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Schizophrenia | 17879154 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 20858243 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Myoclonus-dystonia | 17898012 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164920 | CNVD |
abnormal development | 18461090 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:96935200-96935600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr7:96935600-96937400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr7:96936200-96937400 | Enhancers | Muscle Satellite Cultured Cells | -- |
4 | chr7:96937400-96937600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr7:96942600-96943000 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
6 | chr7:96942800-96943000 | ZNF genes & repeats | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr7:96943000-96943400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
8 | chr7:96943000-96943400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
9 | chr7:96943000-96943800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr7:96943200-96945600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr7:96943400-96943600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
12 | chr7:96943400-96944000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
13 | chr7:96943400-96944600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr7:96943600-96943800 | Enhancers | H9 Cell Line | embryonic stem cell |
15 | chr7:96943800-96947000 | Weak transcription | H9 Cell Line | embryonic stem cell |
16 | chr7:96945600-96946000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |